Revolution Medicines Inc (RVMD)

Feb 19, 2025

Revolution Medicines to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - The Manila Times

Feb 19, 2025

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Feb 19, 2025

Feb 19, 2025

Revolution Medicines Q4 Earnings Coming: Will Their Cancer Drug Pipeline Show Progress? - StockTitan

Feb 19, 2025

Feb 19, 2025

(RVMD) Proactive Strategies - Stock Traders Daily

Feb 19, 2025

Feb 17, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN

Feb 17, 2025

Feb 15, 2025

Wilmington Savings Fund Society FSB Sells 15,167 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 15, 2025

SG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 15, 2025

Empowered Funds LLC Purchases New Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 14, 2025

Mirae Asset Global Investments Co. Ltd. Sells 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 14, 2025

Feb 14, 2025

Wingate Wealth Advisors Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 14, 2025

Feb 13, 2025

WCM Investment Management LLC Takes $6.80 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 13, 2025

Feb 10, 2025

Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect? - MSN

Feb 10, 2025

Feb 08, 2025

(RVMD) Trading Advice - Stock Traders Daily

Feb 08, 2025

Feb 08, 2025

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025

Feb 07, 2025

Revolution Medicines Inc [RVMD] stock for 97,443 USD was sold by Cislini Jeff - Knox Daily

Feb 07, 2025

Feb 07, 2025

Stock Performance Spotlight: Revolution Medicines Inc (RVMD) Ends the Day at 43.57, Down by -1.54 - The Dwinnex

Feb 07, 2025

Feb 06, 2025

An analyst sees good growth prospects for Revolution Medicines Inc (RVMD) - SETE News

Feb 06, 2025

Feb 05, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Stake Lifted by KBC Group NV - Defense World

Feb 05, 2025

Feb 05, 2025

China Universal Asset Management Co. Ltd. Buys 29,853 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 05, 2025

Feb 04, 2025

Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances - MSN

Feb 04, 2025

Feb 03, 2025

Revolution Medicines’ SWOT analysis: stock shows promise amid cancer treatment advances - Investing.com Nigeria

Feb 03, 2025

Feb 03, 2025

Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances By Investing.com - Investing.com South Africa

Feb 03, 2025

Feb 03, 2025

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates - MSN

Feb 03, 2025

Feb 03, 2025

Are Investors Undervaluing Revolution Medicines, Inc. (NASDAQ:RVMD) By 49%? - Simply Wall St

Feb 03, 2025

Jan 31, 2025

Is Revolution Medicines, Inc. (NASDAQ:RVMD) Trading At A 49% Discount? - Yahoo Finance

Jan 31, 2025

Jan 30, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Brokerages - Defense World

Jan 30, 2025

Jan 29, 2025

Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025

Jan 29, 2025

RAS Cancer Breakthrough? Revolution Medicines CEO Takes Center Stage at Major Biotech Event - StockTitan

Jan 29, 2025

Jan 28, 2025

Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade) - Seeking Alpha

Jan 28, 2025

Jan 27, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Analysts - MarketBeat

Jan 27, 2025

Jan 24, 2025

Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround - MSN

Jan 24, 2025

Jan 23, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials By Investing.com - Investing.com South Africa

Jan 23, 2025

Jan 22, 2025

Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock - MSN

Jan 22, 2025

Jan 22, 2025

Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 19, 2025

Sandy Cove Advisors LLC Acquires Shares of 42,008 Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Jan 19, 2025